secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ginkgo Bioworks Holdings, Inc. (DNA)
CIK:        0001830214
Form:       8-K
Filed at:   2023-05-05T23:59:59+00:00
Accession:  0000950170-23-018074
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ginkgo Bioworks appoints Steven Coen as Chief Accounting Officer; Marie Fallon resigns
--------------------------------------------------------------------------------

- Marie Fallon resigns as CAO effective May 15, 2023; she will remain through June 2 and then as consultant.
- Steven Coen appointed CAO effective same date, with annual base salary of $400,000 and $1.5M equity grant vesting over 4 years.
- Coen brings over 30 years experience, most recently Corporate VP & Controller at Charles River Laboratories (annual revenues ~$4B).
- Fallon's resignation is personal, not due to any disagreement with the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1830214/000095017023018074/0000950170-23-018074-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1830214/000095017023018074/dna-20230501.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-018074

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer